More attention should be paid to clarifying the decreased expression mechanism of TRIM21 in RCC tissues, and other possible SREBF1 regulatory mechanisms, which may provide a better understanding of the theoretical basis for targeting TRIM21-SREBF1 molecule as a therapy for RCC. The gene discussed is SREBF1; the disease is renal cell carcinoma.